Skip to content
Open menu Close menu

Professor Alison Blenkinsopp

PositionProfessor of the Practice of Pharmacy
LocationM28 Richmond Building
DepartmentPharmacy & Medical Sciences
Feedback Hours0.8FTE
Telephone01274 234698
LinkedInVisit my LinkedIn profile

Research Interests (key words only)

Medicines optimisation, safe use of medicines, care transitions, primary care, community pharmacy

PhD Supervision

Supervises doctoral students in the Medicines Optimisation Research Group and in UoB's Dementia Doctoral Training Centre.

Teaching and Supervisory Responsibilities

Contribute teaching to Stage 1, Stage 3 and Stage 4 MPharm.

Administrative Responsibilities

  • Member, Pharmacy & Medical Sciences Leadership Board
  • Line manager for 7 academic staff colleagues
  • Career Development Mentor for 5 colleagues
  • Research Lead, Medicines Optimisation group
  • Executive Board Member, Yorkshire & Humber NIHR Patient Safety Translational Research Centre (PSTRC)
  • Academic Board Member, Wolfson Centre for Applied Health Research (Leeds/Bradford Health Collaboration)


Alison currently holds research Chair in the Practice of Pharmacy at University of Bradford where she leads the Medicines Optimisation research group, and is a member of the School of Pharmacy & Medical Sciences Leadership Board and MPharm teaching team.

A leading applied health research leader in the field of medicines optimization, her studies develop and test interventions to improve safety and maximize effective use of medicines for patient benefit. She has research leadership roles in University of Bradford’s Dementia Doctoral Training Centre and Yorkshire & Humber NIHR Patient Safety Translational Research Centre.

Her current national medicines and pharmacy policy roles include Chair of national Pharmacy Health & Social Care Network, and member of the CQC Medicines Optimisation Group. She is lead author of best-selling pharmacy textbook 'Symptoms in the Pharmacy' now in its 7th edition and published in five languages.

Study History

  • 1981: BPharm (1st), University of Bradford
  • 1988: DPhil, Aston University
  • 1992: Cert. Managing Health Services, Open University

Professional History

  • 1981: MRPharmS
  • 1982-1988: Lecturer in Pharmacy Practice / Part-time PhD studies Aston University
  • 1988-present: Self employed consultant in pharmacy and health care
  • 1988-1991: Lecturer in Pharmacy Practice, University of Bradford
  • 1991-1995: Director, NHS Centre for Pharmacy Postgraduate Education (England), North West Regional Health Authority/University of Manchester
  • 1995-1999: Senior Lecturer in Health Services Research, Keele University Department of Medicines Management (0.6WTE)
  • 1999-2011: Professor of the Practice of Pharmacy, Department of Medicines Management, Keele University School of Pharmacy (0.6WTE)
  • 2001: Charter Gold Medal of the Royal Pharmaceutical Society of Great Britain
  • 2002: Fellowship of the Royal Pharmaceutical Society of Great Britain
  • 2009: OBE (Services to Healthcare)
  • 2015: Faculty Fellowship, Royal Pharmaceutical Society

Professional Activities


  • Member, Scientific Advisory Board, Pharmacy Research UK
  • Member, CQC Medicines Optimisation Group
  • Deputy Editor, International Journal of Pharmacy Practice
  • Chair, national pharmacy Health & Social Care Network


  • Deputy Chair, National Joint Formulary Committee (BNF)
  • Member, MHRA Committee on Safety of Medicines 1999-2005
  • Council of the Royal Pharmaceutical Society of Great Britain 1988-2006

Research Areas

The University of Bradford’s Medicines Optimisation research group’s strategic themes are in safe use of medicines for older people at transitions (across care settings and of life/disease stage). 

Dementia, cardiology and diabetes are the group’s clinical research focus in the context of the multiple morbidities inevitably associated with older age and from which polypharmacy arises.

Safe Use of Medicines is one of four themes in the Yorkshire & Humber Patient Safety Translational Research Centre (PSTRC) where we work with colleagues from University of Leeds and from Bradford Teaching Hospitals Trust with a focus on improving safety through patient-centred interventions that are co-designed with patients and NHS staff. Using health services research methods, our studies establish how current health systems and patient pathways can be enhanced to improve safety and quality of care for patients. By studying the experiences of patients and healthcare staff interventions are co-produced.

The research is characterized by strong and effective academic collaborations together with close working with patients and other stakeholders in NHS and social care. Recently-awarded research funding is almost £4 million from sources including NIHR (Patient Safety Translational Research Centre & Programme Grant for Applied Research, PGfAR), Alzheimer’s Society, and partnerships with NHS Trusts in the region.

Current Projects

Alison is currently:

  1. Theme lead for Safe Use of Medicines in the Yorkshire & Humber NIHR Patient Safety Translational Research Centre (PSTRC) with a programme of work on improving safety through patient-centred deprescribing in polypharmacy (Deciding to Deprescribe).

  2. Joint Chief Investigator (with Dr Peter Gardner, Head of Psychology at University of Leeds) of the NIHR ISCOMAT (Improving Safety and Continuity of Medicines management At Transitions of care) research programme. A 5-year programme developing and testing a complex intervention across the patient journey after a hospital admission for heart failure.

  3. Workstream lead/co-app in a NIHR Programme: Accessing medicines at end-of-life: a multi- stakeholder, mixed method evaluation of service led by CI Prof Sue Latter (University of Southampton) with Prof Mike Bennett (University of Leeds). This study builds on previous collaborative work in the NIHR IMPACCT programme on improving pain from advanced cancer in the community.

  4. Medicines optimisation theme lead in UoB’s Dementia Doctoral Traning Centre which focuses on transitions in care setting and disease/life stages and lead supervisor for two of its seven Doctoral fellowships.

Research Collaborations

  • University of Leeds
  • University of Southampton
  • Bradford Institute for Health Research & Bradford Teaching Hospitals Trust
  • Leeds and Sheffield NHS Trusts
  • National Institute for Cardiovascular Outcomes Research (NICOR)
  • GP Clinical Information Systems providers (TPP SystmOne; EMIS)
  • Community Pharmacy West Yorkshire


  • 2015-present: Member, NIHR Clinical Doctoral Fellowships Panel
  • 2013-present: Member, Scientific Advisory Board, Pharmacy Research UK
  • 2008-present: Chair, National Pharmacy Health & Social Care Network
  • 1996-present: Educational Adviser, Communications International Group


See Professor Blenkinsopp's publications on Bradford Scholars.

  • Fylan E, Armitage G, Naylor D, Blenkinsopp A. A qualitative study of patient involvement in medicines management after hospital discharge: an under-recognised source of systems resilience. BMJ Quality & Safety 2017. In Press
  • Ziegler L, Blenkinsopp A, Bennett M. Palliative care prescribing in England; analysis of medical and non-medical activity 2011-2015. Palliative Care Medicine 2017. In Press. 
  • Ziegler L, Mulvey M, Blenkinsopp A, Petty D, Bennett MI. Opioid prescribing for patients with cancer in the last year of life: A longitudinal population cohort study. Pain. 2016; 157 (11):2445-2451. PMID: 27626624 DOI: 10.1097/j.pain.0000000000000656.
  • Elson R, Cook H, Blenkinsopp A. Patients' knowledge of new medicines after discharge from hospital: What are the effects of hospital-based discharge counseling and community-based medicines use reviews (MURs)? Res Social Adm Pharm. 2016 May 13. pii: S1551-7411(16)30022-5. doi: 10.1016/j.sapharm.2016.05.001.
  • Community pharmacists' experience and perceptions of the New Medicines Service (NMS).  Lucas B, Blenkinsopp A. Int J Pharm Pract. 2015 Dec; 23(6):399-406. doi: 10.1111/ijpp.12180. Epub 2015 Feb 25
  • Ziegler L, Bennett M, Blenkinsopp A, Coppock S. Non-medical prescribing in palliative care: a regional survey. Palliat Med. 2015 Feb; 29(2):177-81. doi: 10.1177/0269216314557346. Epub 2014 Dec 12. PMID: 25501312
  • Gerard K, Tinelli M, Latter S, Smith A, Blenkinsopp A. Patients' valuation of the prescribing nurse in primary care: a discrete choice experiment. Health Expect. 2015 Dec;18(6):2223-35. doi: 10.1111/hex.12193. Epub 2014 Apr 11
  • Smith A, Latter S, Blenkinsopp A. Safety and quality of nurse independent prescribing: a national study of experiences of education, continuing professional development clinical governance. J Adv Nurs. 2014 Nov;70(11):2506-17. doi: 10.1111/jan.12392. Epub 2014 Apr 4
  • Urban R, Armitage G, Morgan J, Marshall K, Blenkinsopp A & Scally A. Custom and practice: A multi-center study of medicines reconciliation following admission in four acute hospitals in the UK. Res Social Adm Pharm. 2014 Mar-Apr;10(2):355-68. doi: 10.1016/j.sapharm.2013.06.009. Epub 2014 Feb 14
  • Ngwerume K, Watson M, Bond C, Blenkinsopp A. An evaluation of an intervention designed to improve the evidence-based supply of non-prescription medicines from community pharmacies. Int J Pharm Pract. 2015 Apr;23(2):102-10. doi: 10.1111/ijpp.12118. Epub 2014 May 20
  • Tinelli M, Blenkinsopp A, Latter S, Smith A, Chapman SR. Survey of patients' experiences and perceptions of care provided by nurse and pharmacist independent prescribers in primary care. Health Expect. 2015 Oct;18(5):1241-55. doi: 10.1111/hex.12099. Epub 2013 Jun 24
  • Alam MF, Blenkinsopp A, Cohen D, Davies P, Hodson K, Hughes L, James D, Longley M, O’Brien C, Smith M, Turnbull L. Evaluation of the Discharge Medicines Review Service: Final Report (2014) Universities of South Wales, Cardiff & Bradford
  • Savage I, Blenkinsopp A, Bennett M. ”Like doing a jigsaw with half the pieces missing”: community pharmacists and the management of cancer pain in the community. Int J Pharm Pract 2013; 21(3):151-60
  • McLean SL, Blenkinsopp A, Bennett MI. Using haloperidol as an antiemetic in palliative care: informing practice through evidence from cancer treatment and postoperative contexts. J Pain Palliat Care Pharmacother. 2013 Jun;27(2):132-5. doi: 10.3109/15360288.2013.782937. Epub 2013 Apr 29
  • Mills E, Blenkinsopp A, Black P. Quality management in pharmacy pre-registration training: Current practice. Pharm Educ 2013 (13) July 7
  • Mills E, Blenkinsopp A, Black P. Quality management in Medical Foundation training: Lessons for pharmacy. Pharm Educ 2013 (13) July 7
  • Mills E, Blenkinsopp A, Black P. Quality management in pharmacy pre-registration training: Recommendations for the future. Pharm Educ 2013 (13) July 7
  • Blenkinsopp A, Horgan J, McManus R, Little R, George E, Silcock J, Beach J, Smith S. (2013) Evaluation of costs and benefits of a community pharmacy cardiovascular risk assessment service
  • Blenkinsopp A, Bond C, Raynor DK. Medication Reviews. Br J Clinical Pharmacol 2012, 74(4):573-80
  • Bond C, Raynor DK, Blenkinsopp A. Prescribing Partnerships. Br J Clinical Pharmacol 2012, 74(4):581-8
  • De Simoni A, Mullis R, Clyne W, Blenkinsopp A. Medicines optimisation in primary care: can community pharmacies deliver? Editorial. Brit J Gen Pract 2012, 62: 398-9
  • Gerard K, Tinelli M, Latter S, Blenkinsopp A, Smith A, Chapman S. Valuing the extended role of prescribing pharmacist in general practice: Results from a discrete choice experiment. Value in Health 2012, 15(5):699-707
  • Latter S, Smith A, Blenkinsopp A, Nicholls P, Little P, Chapman S. Are nurse and pharmacist independent prescribers making clinically appropriate prescribing decisions? An analysis of consultations using the Medication Appropriateness Index. J Hth Serv Res Policy 2012, 17(3):149-56
  • Latter S, Blenkinsopp A. Non-medical prescribing: current and future contribution of pharmacists and nurses. Int J Pharm Pract. 2011 Dec;19(6):381-2
  • Latter S, Blenkinsopp A, Smith A, Chapman S, Tinelli M et al. Evaluation of nurse and pharmacist independent prescribing. Final Report (2011). Department of Health Policy Research Programme. University of Southampton / Keele University
  • Bennett MI, Bagnall AM, Raine G, Closs SJ, Blenkinsopp A, Dickman A, Ellershaw J. Educational interventions by pharmacists to patients with chronic pain: systematic review and meta-analysis. Clin J Pain 2011; 27(7):623-30
  • Tinelli M, Blenkinsopp A, Bond CM. Development and validation of a patient satisfaction score for a community pharmacy medicines management service Int J Pharm Pract 2011; 19(3):144-55
  • Tann J, Blenkinsopp A, Grime J, Evans A. The Great Boundary Crossing: Perceptions on training pharmacists as prescribers in the UK. Health Ed J 2010; 69: 183-191
  • Horgan JMP, Blenkinsopp A, McManus RJ. Evaluation of a cardiovascular disease opportunistic risk assessment pilot (‘Heart MOT’ service) in community pharmacies. J Pub Hlth 2010; 32:110 – 116
  • Watson MC, Blenkinsopp A. The feasibility of providing community pharmacy based services for alcohol misuse: a systematic review. Int J Pharm Pract 2009; 17(4): 199-205
  • Blenkinsopp A, Holmes J, Mitra G, Pringle M. Joining up self care: evaluation of a Primary Care Trust-wide programme of support for self care. Primary Care Research and Development 2009; 10: 83-89
  • Bond CM, Blenkinsopp A, Inch J, Celino G, Gray N. The effect of the new community pharmacy contract on the community pharmacy workforce (Research Monograph). Pharmacy Practice Research Trust, London 2008
  • Phelan P, Blenkinsopp A, Foster ME, Thomas E, Hay EM. Pharmacist-led medication review for knee pain in older adults: content, process and outcomes. Int J Pharm Pract 2008; 16: 347-55
  • Blenkinsopp A, Celino G, Bond C, Inch J, Gray N. Medicines use review: adoption and spread of a new service innovation. International Journal of Pharmacy Practice 2008; 16(4): 271-276
  • Tann J, Blenkinsopp A, Evans A, Grime J. Beating the Bounds? General medical practitioner (GP) and pharmacist perspectives on the innovation of pharmacist prescribing in the UK National Health Service. Prometheus 2008; 26: 125-139
  • Bissell P, Blenkinsopp A, Short D, Mason L. Patients’ views and experiences of a medicines management service. Health and Social Care in the Community 2008; 16(4): 363-369
  • Blenkinsopp A, Tann J, Evans A, Grime JC. Opportunity or threat? GP perceptions of pharmacist prescribing. International Journal of Pharmacy Practice
  • Blenkinsopp A, Bond C. The potential and pitfalls of medicines management: what have we learned so far? Disease Management and Health Outcomes 2008; 16(2):79-86
  • Tinelli M, Bond C, Blenkinsopp A, Jaffray M, Watson M, Hannaford P. Patients’ experiences with a community pharmacy medications management service: focus on attitudes, expectations and satisfaction. Ann Pharmacother 2007; 41: 1962-70
  • Raynor DK, Blenkinsopp A, Knapp P Knapp P, Nicolson DJ, Grime J, Pollock K , Dorer G, Gilbody S, Dickinson D, Maule AJ, Spoor P. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technol Assess. 2007 (5):iii, 1-160. Review
  • Grime J, Blenkinsopp A, Raynor DK, Pollock K, Knapp P. The role and value of written information for patients about individual medicines: a systematic review Health Expectations 2007; 10: 286-298
  • Blenkinsopp A, Hassey A, Dorer G. Medicines in primary care: towards a patient-centred approach to quality. Qual Prim Care 2007; 15: 213-9
  • Blenkinsopp A, Celino G, Bond CM, Inch J. Medicines Use Review: The first year of a new community pharmacy service. PharmJ 2007; 278: 218-223
  • The community pharmacy medicines management evaluation project team. The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. Family Practice 2007 24(2): 189-200
  • Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol. 2007; 63(2):148-56


  • Blenkinsopp A, Paxton P, Blenkinsopp J. Symptoms in the Pharmacy (7th ed). Oxford: Wiley: 2013
  • Chambers R, Wakley G, Blenkinsopp A. Promoting patients’ self care in primary care. Oxford: Radcliffe Press 2006
  • Blenkinsopp A, Panton RS, Anderson A. Health promotion for community pharmacists (2nd ed). Oxford University Press 2000

Book Chapters

  • Blenkinsopp A, Anderson A, Panton R. (2015) Promoting Health. In Taylor P, Harding G, eds. Pharmacy Practice. Oxford University Press. 2015
  • Blenkinsopp A, Kinnear M. (2011) Research and Development. In: Hospital Pharmacy (ed. Stephens M). Pharmaceutical Press.
  • Anderson C, Blenkinsopp A. (2010) Health Education opportunities. In: Pharmaceutical Public Health (ed Krska J). Pharmaceutical Press, London
  • Blenkinsopp A, Dorer G, Duerden M, Jester R. (2009) Interface of care and communication. In: Medication Safety. Cambridge University Press
  • Blenkinsopp A, Gray N. (2008) Online information and supply systems for patients, the public and professionals. In Bond, ed. Harnessing Health Information: Using medicines information. Radcliffe Medical Press, Oxford
  • Armstrong M, Anderson C, Blenkinsopp A, Lewis R. (2005) Promoting health through community pharmacies. In Scriven, ed. Health Promoting Practice. Palgrave Macmillan
  • Blenkinsopp A. (2004) Ongoing support - the postprescription phase. In Bond C, ed. Concordance. London : Pharmaceutical Press
  • Blenkinsopp A, Bond C. (2004) Self-care and medication. In Jones et al, ed. Textbook of Primary Medical Care. Oxford: University Press
  • Blenkinsopp A, Bond C. (2004) The future healthcare workforce in pharmacy. In Celia Davies, ed. The future health workforce. Hampshire: Palgrave Macmillan
  • Anderson C, Blenkinsopp A. (2001) Health, disease and health education. In Harman R, ed. Handbook of Pharmacy Health Education. Cambridge: Cambridge University Press


Large scale studies to evaluate medicines management and the effects of major medicines policy initiatives and which have influenced national and local health services, including:

  • The first detailed analysis showing that cancer-related pain is being undertreated. This major study of the prescribing demonstrated the relatively late onset and short duration of strong opioid treatment in cancer patients before death. The findings have implications for improving medicines optimisation for pain in patients with advanced cancer.

  • Evaluation of the quality and safety of nurse and pharmacist independent prescribing in order to inform planning for current and future prescribers.

  • Research to evaluate the impact of changes to the national community pharmacy NHS contractual framework on patients, practitioners and care delivery.

  • The first systematic review of evidence of the contribution of community pharmacy to improving the public’s health was co-led by Alison with Professor Claire Anderson. This work was instrumental in informing a Department of Health White Paper and the subsequent development of the Healthy Living Pharmacy model in England.

Public/Academic/Stakeholder Engagement

The research is characterised by meaningful involvement of patients from the outset, utilisation of recognised methodologies (for example, experience-based co-design where patients and staff work together on intervention design), and innovative practice (for example routine inclusion of a Patient-Led Steering Group in studies). Alison works and collaborates with an extensive network of stakeholders at individual and organisational levels that includes policy makers, regulators, clinicians, patients, professional bodies and academics.


Share this